Hospital

The Pharmacy Times® Pharmacy Hospital Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to hospital and health-system pharmacists.

Latest News

Abelacimab reduces major and clinically relevant non-major bleeding by 62%. | Image Credit: DIgilife | stock.adobe.com
Abelacimab Reduces Major, Clinically Relevant Non-Major Bleeding Compared WIth Rivaroxaban

January 24th 2025

Abelacimab (Anthos Therapeutics Inc) is a novel factor XI inhibitor being investigated for the reduction of bleeding for patients with atrial fibrillation.

Image credit: Kzenon | stock.adobe.com
Enhancing Medication Safety Through USP Health Literacy Standards and Solutions

January 24th 2025

Muscular dystrophy. A group of diseases that cause progressive weakness and loss of muscle mass. abnormal genes interfere with the production of proteins needed to form healthy muscle - Image credit: Thipphaphone | stock.adobe.com
DYNE-101 Receives FDA Fast Track Designation to Treat Myotonic Dystrophy

January 23rd 2025

FDA Grants Fast Track Designation to [18F]Florbetaben for Diagnosis of Cardiac Amyloidosis
FDA Grants Fast Track Designation to [18F]Florbetaben for Diagnosis of Cardiac Amyloidosis

January 23rd 2025

Cholesterol plague in artery -- Image credit: Rasi | stock.adobe.com
Potential Safety Concerns With Evinacumab

January 23rd 2025

More News